Emerging in the field of obesity management, retatrutide presents a unique method. Different from many existing medications, retatrutide operates as a dual agonist, at once engaging both glucagon-like peptide-1 (GLP-1) https://zubairmbiq519496.ourcodeblog.com/39004475/the-novel-retatrutide-a-glp-and-gip-sensor-agonist